Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Infosys - 2QFY22 Result Update - Superior Execution Deserves Multiple Rerating; Raise TP to Rs2,120 - Reliance Research

Posted On: 2021-10-14 22:22:36 (Time Zone: IST)


Strong Print; One More Revenue Guidance Upgrade

2QFY22 revenue is at US$3.99bn, which is 110bps above our estimate of US$3.95bn. The sequential constant currency growth is at 6.3% vs. our estimate of 5% (consensus: 6%), driven by a broad-based growth across industries. EBIT margin stood at 23.6%, substantially ahead of our estimate of 22.2%, driven by a better-than-expected operating leverage and lower-than-expected wage inflation. Net profit stood at Rs54.2bn, which is 3.4% above our estimate of Rs52.1bn, driven by an outperformance in both revenue growth and EBIT margin. Large deal signings remained healthy at US$2.15bn. Management's commentary on the demand environment and deal pipeline remained strong. Infosys (INFO) upgraded its FY22 revenue growth guidance at 16.5-17.5% in CC terms vs. the prior 14-16%. Additionally, the company retained the EBIT margin guidance at 22-24%. We expect INFO to continue to gain market share in the current technology upcycle. We have raised the FY22E-FY24E EPS estimates by (0.1)-3.9% (previous note of Mar'21) driven by an improved revenue growth visibility. We retain the BUY recommendation and raise the target price to Rs2,120 (vs. the prior Rs1,920) and value the stock at 28.5x (earlier 27x) FY24E earnings.

Broad-based Growth Across Verticals; Sharp Attrition Spike In Line With Larger Peers

(1) Digital revenue reported a growth of 42.4% YoY and is at ~56% of revenue. (2) INFO reported a broad-based revenue growth across verticals and geographies, and the growth was led by North America and manufacturing vertical. (3) Voluntary LTM attrition in IT services stood at 20.1%, compared to 13.9% in 1QFY22. Management expects the high attrition to ease in the next couple of quarters. (4) During 2QFY22, the company added a net work force of ~11.6k employees. It targets to hire 45k (vs. the earlier 35k target) graduates over FY22. (5) INFO stated it will launch a new company structure in the coming weeks. 6) The board has announced an interim dividend of Rs15/share.

Execution Surprise Led by Operating Efficiencies

INFO reported 2QFY22 EBIT margin of 23.6% (10bps QoQ), which was 110bps higher than consensus, as operating efficiencies (80bps), lower SG&A cost (50bps) and Fx gain (20bps) offset wage inflation (110bps) and a rise in sub-contractor cost (40bps). Additionally, we expect a limited margin upside for FY22 due to a higher SG&A cost (higher attrition and resumption of offices) and accelerated hiring over the next two quarters. We estimate an EBIT margin of 24-24.7% over FY22E-FY24E.

Superior Execution Deserves Premium Valuation

At CMP, INFO trades at 26.4x/23.0x FY23E/FY24E EPS, which is at 10% discount to the larger peer TCS. Going forward, we expect INFO to report a superior growth vs. the top 4 Indian IT peers, driven by a surge in large deals and acceleration in the digital revenue share. Also, a stable management keeps INFO in a better position to make bolder decisions and pursue aggressive market share gain. We believe the stock deserves a rerating, considering the industry-leading double-digit revenue growth, rising share of digital business (56% of revenue), elevated EBIT margin levels vs. pre-Covid levels and a consistent capital allocation policy. Thus, we retain the BUY recommendation. We have shifted to a 1-year target price from the earlier 2-year. As we enter 2HFY22, instead of rolling forward our valuation, we maintain it based on FY24E earnings and shift to a 1-year target price of Rs2,120.

Link to the report

Shares of Infosys Limited was last trading in BSE at Rs. 1715.50 as compared to the previous close of Rs. 1708.75. The total number of shares traded during the day was 495333 in over 20693 trades.

The stock hit an intraday high of Rs. 1784.05 and intraday low of 1698.25. The net turnover during the day was Rs. 860872760.00.


Click here to send ur comments or to feedback@equitybulls.com

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Mutual Fund Review - November, 2021 - ICICI Direct

Natraj Proteins Ltd Q2FY22 PAT at Rs. 6.70 crore

PMC Fincorp Ltd reports PAT of Rs. 1.15 crore in Q2FY22

Alkyl Amines Chemicals Ltd Q2 PAT declines to Rs. 54.09 crores

Shangar Decor Ltd Q2FY22 net profit at Rs. 6.06 lakhs

Maintain SELL on Asian Paints - Demand rebound strong; profitability cut steeper - HDFC Securities

Mphasis - 2QFY22 Result Update - Growth Resiliency Continues; Raise Target Price - Reliance Research

Gateway Distriparks - Rail continues to drive earnings - ICICI Securities

JSW Steel - Start of EBITDA contraction cycle - ICICI Securities

Shoppers Stop - Beneficiary of faster than expected recovery - ICICI Securities

Asian Paints - Q2FY22 Result Update - ICICI Securities

TVS Motor Company - EVs now at the center of its global ambitions - ICICI Securities

Havells India - Strong demand across regions; profitability likely to be muted in H2FY22 - ICICI Securities

Tata Communications - Rising visibility on revenue growth - ICICI Securities

Angel Broking - Business momentum intact for strong earnings growth - ICICI Securities

Q2FY22 Result Update - Rallis India - ICICI Direct

Q2FY22 Result Update - Navin Fluorine - ICICI Direct

Q2FY22 Result Update - Shoppers Stop - ICICI Direct

Company Update - Mastek Ltd - ICICI Direct

Q2FY22 Result Update - JSW Steel - ICICI Direct

Q2FY22 Result Update - VST Industries - ICICI Direct

HDFC Life Insurance - Q2FY22 First Cut - ICICI Direct

Federal Bank - Q2FY22 First Cut - ICICI Direct

Company Update - Taj GVK Hotels - ICICI Direct

Q2FY22 Result Update - Indian Hotels - ICICI Direct

Inox Leisure - Q2FY22 First Cut - ICICI Direct

Supreme Industries - Q2FY22 First Cut - ICICI Direct

Q2FY22 Result Update - Biocon Ltd - ICICI Direct

PVR Ltd - Q2FY22 First Cut - ICICI Direct

Q2FY22 Result Update - Asian Paints - ICICI Direct

Quant Pick - RBL Bank - ICICI Direct

Q2FY22 Result Update - IIFL Securities - ICICI Direct

Q2FY22 Company Update - Bank of Baroda - ICICI Direct

Q2FY22 Result Update - Syngene International - ICICI Direct

Company Update - Sonata Software - ICICI Direct

Q2FY22 Result Update - Gateway Distriparks - ICICI Direct

Q2FY22 Result Update - Tata Communications - ICICI Direct

Q2FY22 Result Update - Havells India - ICICI Direct

Mphasis - 2QFY22 Result Update - Growth Resiliency Continues; Raise Target Price - Reliance Research

Maintain ADD on Havells India - Outperformance continues; miss on margin - HDFC Securities

Indraprastha Gas - Company Update - EV vs CNG; TCO Economics Favour CNG - Reliance Research

FinTech Playbook - Discount Brokers - 'Nudging' the long tail of standalone brokers - HDFC Securities

Tata Communication - Revenue growth remains muted - YES Securities

Havells India Ltd - Q2FY22 Result Update - YES Securities

ICICI Lombard General Insurance - Q2FY22 Result Update - YES Securities

Syngene International Ltd - Lack of near term triggers - YES Securities

Mphasis - Q2FY22 First Cut - YES Securities

IndiaMART InterMESH - Q2FY22 First Cut - YES Securities

Sterlite Technologies - Q2FY22 First Cut - YES Securities

Can Fin Homes - Q2FY22 First Cut - YES Securities


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020